2024 -
now Vice President of Business Development @
2021 -
now Senior Director Business Development @
2018 -
2020 Investment Analyst @
2014 -
2018 Postdoctoral Researcher @
2017 -
2017 Private Equity Analyst @
2012 -
2014 PhD in Biotechnology - Structural Enzymopathology Unit @ Instituto de Biomedicina de Valencia - Spanish National Research Council
2012 -
2013 PhD guest student in Metabolism Department @ Kinderspital Zürich - Universitäts Kinderklinik
2009 -
2011 PhD in Biotechnology- Molecular Recognition Department @
2011 -
2011 Assistant Professor Molecular Human Pathology @
2007 -
2007 Practicum Student @
Carmen Diez Education
CELforPharma
(Pharma-Biotech Product and company Valuation)
2018
-
2018
Universidad Politécnica de Valencia
PhD in Biotechnology (Metabolic rare disorders)
2009
-
2015
Universidad Nacional de Educación a Distancia - U.N.E.D.
Master in Teacher Training for Middle School and High School (Technology)
2010
-
2011
Universitat Politècnica de València (UPV)
Master in Biomedicine (Biotechnology)
2010
-
2011
KTH Royal Institute of Technology
Final Project (Biotechnology)
2008
-
2009
Universitat Politècnica de València (UPV)
Agronomic Engineer (Specialization in Biotechnology)
2003
-
2008
American School of Valencia 1988
-
2003
CELforPharma
Elementary School. American School of Valencia
null
Carmen Diez Summary
Carmen Diez, based in Spain, is currently a Vice President of Business Development at NUVISAN The Science CRO. Carmen Diez brings experience from previous roles at NUVISAN The Science CRO, Nextech Invest, Kinderspital Zürich and HBM Partners AG. Carmen Diez holds a 2018 - 2018 CELforPharma. Carmen Diez has 3 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.